GlaxoSmithKline will change its approach to patenting to make its medicines more affordable in developing countries. The pharmaceutical company says the move will cover about 85 countries and a combined population of more than 2 billion people. The move comes amid criticism that the industry’s new drugs are too expensive for many people in Africa, Asia and Latin America.
Read more at GSK Won’t Seek Drug Patents In Poor Countries
Do more by adding you voice to declare that medicines must be affordable to all.
Act Now Watch how The Dispensary of Hope moves medicines to the most underserved communities